Improving the Management of Acute Coronary Syndromes in the Emergency Department

PHASE4CompletedINTERVENTIONAL
Enrollment

705

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Acute Coronary Syndrome
Interventions
DEVICE

Point of Care testing

"The investigators will implement 6 months of randomized testing periods, 2 weeks each. During this 2 week block, cardiac biomarkers will be tested at the bedside in the ED using the Triage Cardiac Panel that will test for CK-MB, Myoglobin, and Troponin I.~Each blood sample that is take for point of care testing will be saved. The plasma from the saved sample will be frozen and the sample will be sent to an off-site testing center for high sensitivity troponin testing.~All patients will be followed at the 30-day mark and those patients who are discharged home from the ED will be followed within 48 hours as well."

Trial Locations (1)

11215

New York Methodist Hospital, Brooklyn

All Listed Sponsors
collaborator

Alere San Diego

INDUSTRY

collaborator

New York State Department of Health

OTHER_GOV

lead

Integrated Medical Research LLC

OTHER

NCT01563250 - Improving the Management of Acute Coronary Syndromes in the Emergency Department | Biotech Hunter | Biotech Hunter